IL317723A - N-(2-(3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)- quinoline-4-carboxamides - Google Patents
N-(2-(3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)- quinoline-4-carboxamidesInfo
- Publication number
- IL317723A IL317723A IL317723A IL31772324A IL317723A IL 317723 A IL317723 A IL 317723A IL 317723 A IL317723 A IL 317723A IL 31772324 A IL31772324 A IL 31772324A IL 317723 A IL317723 A IL 317723A
- Authority
- IL
- Israel
- Prior art keywords
- hexan
- carboxamides
- oxoethyl
- azabicyclo
- quinoline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263366700P | 2022-06-21 | 2022-06-21 | |
| PCT/EP2023/066560 WO2023247488A1 (en) | 2022-06-21 | 2023-06-20 | N-(2-(3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)- quinoline-4-carboxamides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL317723A true IL317723A (en) | 2025-02-01 |
Family
ID=87047759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL317723A IL317723A (en) | 2022-06-21 | 2023-06-20 | N-(2-(3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)- quinoline-4-carboxamides |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20230406840A1 (en) |
| EP (1) | EP4543869B1 (en) |
| JP (1) | JP2025525345A (en) |
| KR (1) | KR20250044660A (en) |
| CN (1) | CN119562947A (en) |
| AR (1) | AR129669A1 (en) |
| AU (1) | AU2023288735A1 (en) |
| CA (1) | CA3260241A1 (en) |
| CL (1) | CL2024003889A1 (en) |
| CO (1) | CO2025000307A2 (en) |
| CR (1) | CR20250020A (en) |
| DO (1) | DOP2024000266A (en) |
| IL (1) | IL317723A (en) |
| MA (1) | MA71235A (en) |
| MX (1) | MX2024015642A (en) |
| PE (1) | PE20251704A1 (en) |
| TW (1) | TW202417422A (en) |
| UY (1) | UY40322A (en) |
| WO (1) | WO2023247488A1 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1760076A1 (en) * | 2005-09-02 | 2007-03-07 | Ferring B.V. | FAP Inhibitors |
| EP1931633A2 (en) | 2005-09-05 | 2008-06-18 | Ranbaxy Laboratories Limited | Derivatives of 3-azabicyclo[3.1.0]hexane as dipeptidyl peptidase-iv inhibitors |
| CN113811529A (en) * | 2018-12-21 | 2021-12-17 | 普拉西斯生物技术有限责任公司 | fibroblast-activated protein inhibitor |
-
2023
- 2023-06-20 IL IL317723A patent/IL317723A/en unknown
- 2023-06-20 EP EP23734211.8A patent/EP4543869B1/en active Active
- 2023-06-20 PE PE2024002958A patent/PE20251704A1/en unknown
- 2023-06-20 JP JP2024573691A patent/JP2025525345A/en active Pending
- 2023-06-20 KR KR1020257002003A patent/KR20250044660A/en active Pending
- 2023-06-20 CR CR20250020A patent/CR20250020A/en unknown
- 2023-06-20 MA MA71235A patent/MA71235A/en unknown
- 2023-06-20 WO PCT/EP2023/066560 patent/WO2023247488A1/en not_active Ceased
- 2023-06-20 US US18/337,476 patent/US20230406840A1/en active Pending
- 2023-06-20 CN CN202380047915.5A patent/CN119562947A/en active Pending
- 2023-06-20 AU AU2023288735A patent/AU2023288735A1/en active Pending
- 2023-06-20 CA CA3260241A patent/CA3260241A1/en active Pending
- 2023-06-21 AR ARP230101583A patent/AR129669A1/en unknown
- 2023-06-21 UY UY0001040322A patent/UY40322A/en unknown
- 2023-06-21 TW TW112123334A patent/TW202417422A/en unknown
-
2024
- 2024-12-16 MX MX2024015642A patent/MX2024015642A/en unknown
- 2024-12-17 DO DO2024000266A patent/DOP2024000266A/en unknown
- 2024-12-17 CL CL2024003889A patent/CL2024003889A1/en unknown
-
2025
- 2025-01-14 CO CONC2025/0000307A patent/CO2025000307A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR129669A1 (en) | 2024-09-18 |
| AU2023288735A1 (en) | 2025-02-13 |
| CN119562947A (en) | 2025-03-04 |
| JP2025525345A (en) | 2025-08-05 |
| CL2024003889A1 (en) | 2025-02-07 |
| EP4543869A1 (en) | 2025-04-30 |
| WO2023247488A1 (en) | 2023-12-28 |
| CO2025000307A2 (en) | 2025-01-23 |
| PE20251704A1 (en) | 2025-07-02 |
| MA71235A (en) | 2025-04-30 |
| CA3260241A1 (en) | 2023-12-28 |
| EP4543869B1 (en) | 2026-05-27 |
| DOP2024000266A (en) | 2025-07-15 |
| US20230406840A1 (en) | 2023-12-21 |
| CR20250020A (en) | 2025-05-26 |
| KR20250044660A (en) | 2025-04-01 |
| UY40322A (en) | 2023-12-15 |
| TW202417422A (en) | 2024-05-01 |
| MX2024015642A (en) | 2025-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4081828A4 (en) | SCALING PARAMETERS FOR V-PCC | |
| MA54526A (en) | NEW POLYMORPHIC FORMS OF A TGFBeta INHIBITOR | |
| EP3781357A4 (en) | IMPROVED LIFTING MECHANISM FOR FRAMING NAILER | |
| EP4116039A4 (en) | DRIVE MACHINE | |
| EP3919491A4 (en) | AKT INHIBITOR | |
| EP3898654A4 (en) | FIBROBLAST ACTIVATING PROTEIN INHIBITORS | |
| EP3941612A4 (en) | CARBON AIRGEL CATHODES FOR LITHIUM-SULFUR BATTERIES | |
| EP3998003A4 (en) | WATER-BASED ADHESIVE FOR PAPER STRAW, AND PAPER STRAW USING THE SAME | |
| EP3915262A4 (en) | ENCODER, DECODER AND RELATED METHODS FOR INTERPREDICTION | |
| AU2021390923A9 (en) | "livestock monitoring" | |
| EP3952861A4 (en) | POLYMORPHIC FORMS OF VORUCICLIB, AND METHODS OF MAKING AND METHODS OF USING THE SAME | |
| EP4234740A4 (en) | STEEL PLATE | |
| EP3963995A4 (en) | CHANNEL ACCESS PRIORITY SELECTION | |
| IL320582A (en) | Heterocyclic carboxylate compounds as glycolate oxidase inhibitors | |
| HK40125947A (en) | N-(2-(3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)- quinoline-4-carboxamides | |
| CA3260241A1 (en) | N-(2-(3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)- quinoline-4-carboxamides | |
| HK40102287A (en) | N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)- quinoline-4-carboxamides | |
| EP3964598A4 (en) | GALVANISED STEEL | |
| IL317722A (en) | Solid-state forms of n-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)- 6-morpholinoquinoline-4-carboxamide | |
| IL291187A (en) | Benzyl amine-containing 5,6-heteroaromatic compounds useful against mycobacterial infection | |
| EP4085954A4 (en) | ANESTHESIA MACHINE | |
| EP4036059A4 (en) | COMPOSITION FOR FORMING TIN OXIDE | |
| EP3996252A4 (en) | DRIVE UNIT | |
| CA211415S (en) | Coffret en forme d'hippopotame | |
| GB202314204D0 (en) | 0/.9. f13/9.23 |